BSE filing, BSE: 544629. Summary written from the filing by ALFA Finder's alert engine.
Ravelcare Ltd: key numbers
- Share price
- ₹90.25
- Market cap
- ₹61.90 Cr
- Revenue (annual)
- ₹26.95 Cr
- Net profit (annual)
- ₹5.15 Cr
- P/E (TTM)
- 12.0×Sector 38.3×
- Promoter holding
- 72.94%
- FII holding
- 1.82%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ravelcare Ltd
All →Ravelcare Other Announcement
Ravelcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations. This is a routine compliance disclosure.
Ravelcare Annual General Meeting
Ravelcare Ltd submitted the proceedings of its 8th AGM held on September 23, 2026. Items covered adoption of audited FY26 financials and re-appointment of the MD, WTD, and a retiring director.
Ravelcare Annual Report
Ravelcare Limited has filed its Annual Report for the fiscal year 2025-26, along with the notice for its 8th Annual General Meeting.
Ravelcare Product Launch
Ravelcare Limited launched the 'Ravel PRO' and AI diagnostic skincare range to expand its market presence. These new products are available across major e-commerce platforms.
Ravelcare Management Change
Ravelcare Limited has announced the re-appointment of its Executive Directors, Mr. Ayush Varma and Mr. Maheshkumar Varma, along with Secretarial Auditor M/s. VTSN & Associates LLP.
Ravelcare H2 FY26 Results: Net Profit ₹2 Cr, Up 33.3% YoY
Ravelcare Ltd reported revenue from operations of ₹12.6 Cr (-13.7% YoY) and net profit of ₹2 Cr (+33.3% YoY) for H2 FY26.
- Key figure
- Net profit ₹2 Cr · +33.3% YoY
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.